Peter Grogg
Director/Board Member at BACHEM HOLDING AG
Net worth: 4 116 M $ as of 2024-03-30
Profile
Dr. Peter Grogg is a Chairman at Ingro Finanz AG. He is on the Board of Directors at Kenta Biotech AG and Bachem Holding AG. Dr. Grogg was previously employed as a Vice Chairman-Supervisory Board by Sunstar-Holding AG, a Deputy Chairman by Dottikon Es Holding AG, a Chief Executive Officer by Bachem AG, a Partner by Fox-Chemicals GmbH, a Principal by Ciba Holding AG, a Chairman by MFC Beteiligungs AG, and a Chairman by Pevion Biotech AG. He also served on the board at Berna Biotech AG, GABA AG and Polyphor AG.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
BACHEM HOLDING AG CLASS B
51.94% | 2023-05-11 | 38,957,455 ( 51.94% ) | 3 737 M $ | 2024-03-30 |
DOTTIKON ES HOLDING AG
7.00% | 2023-03-30 | 979,936 ( 7.00% ) | 259 M $ | 2024-03-30 |
BURKHALTER HOLDING AG
10.39% | 2022-12-30 | 1,103,787 ( 10.39% ) | 120 M $ | 2024-03-30 |
Peter Grogg active positions
Companies | Position | Start |
---|---|---|
BACHEM HOLDING AG | Director/Board Member | - |
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Director/Board Member | - |
Ingro Finanz AG
Ingro Finanz AG Financial ConglomeratesFinance Ingro Finanz AG provides investment services. The private company is based in Bubendorf, Switzerland. | Chairman | 2011-01-04 |
Former positions of Peter Grogg
Companies | Position | End |
---|---|---|
DOTTIKON ES HOLDING AG | Director/Board Member | 2012-07-05 |
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Chief Executive Officer | 2001-12-31 |
MFC Beteiligungs AG | Chairman | - |
Sunstar-Holding AG
Sunstar-Holding AG Hotels/Resorts/Cruise linesConsumer Services Sunstar-Holding AG engages in the operation of holiday hotels. The company was founded by Fritz Buser and Ernst Rieder on March 14, 1969 and is headquartered in Liestal, Switzerland. | Director/Board Member | - |
Fox-Chemicals GmbH | Corporate Officer/Principal | - |
Training of Peter Grogg
University of Basel | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
BACHEM HOLDING AG | Health Technology |
DOTTIKON ES HOLDING AG | Process Industries |
SPEXIS AG | Health Technology |
Private companies | 10 |
---|---|
Ciba Holding AG
Ciba Holding AG Chemicals: Major DiversifiedProcess Industries Ciba Holding AG manufactures and markets chemicals that provide color, performance and care for plastics, coatings, textile, paper, home & personal care and other products. The firm provides services to the plastic, rubber, adhesives lubricant, home and personal care, coatings, graphic arts, electronic, detergents and hygiene industries. It operates through four segments Plastic Additives, Coating Effects, Water & Paper Treatment and Textile Effects. The company has offices in Europe, America and Asia. Ciba Holding was founded on April 24, 1996 and is headquartered in Basel, Switzerland. | Process Industries |
Berna Biotech AG
Berna Biotech AG Miscellaneous Commercial ServicesCommercial Services Berna Biotech AG produced and developed immunobiological preparations. It offered respiratory, hepatitis B, pediatric, veterinary and travel vaccines. The company was founded in 1898 and was headquartered in Bern, Switzerland | Commercial Services |
Sunstar-Holding AG
Sunstar-Holding AG Hotels/Resorts/Cruise linesConsumer Services Sunstar-Holding AG engages in the operation of holiday hotels. The company was founded by Fritz Buser and Ernst Rieder on March 14, 1969 and is headquartered in Liestal, Switzerland. | Consumer Services |
Ingro Finanz AG
Ingro Finanz AG Financial ConglomeratesFinance Ingro Finanz AG provides investment services. The private company is based in Bubendorf, Switzerland. | Finance |
GABA AG
GABA AG Medical DistributorsDistribution Services GABA AG manufactures oral care products. Its brands include aronal, elmex and meridol. GABA develops its develops products in the field of dentistry, molecular biology, ergonomy, and others. The company was founded in 1917 by Dr. Hermann Geiger and is headquartered in Therwil, Switzerland. | Distribution Services |
Pevion Biotech AG
Pevion Biotech AG Pharmaceuticals: MajorHealth Technology Pevion Biotech AG develops efficient and safe vaccines based on proprietary technology. The firm provides preclinical and clinical development of prophylactic/therapeutic vaccines based on its virosome-based technology platform. The company was founded in 2002 and is headquartered in Ittigen, Switzerland. | Health Technology |
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
Fox-Chemicals GmbH | |
MFC Beteiligungs AG | |
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Peter Grogg